Obesity Associated Disease in People with Mental Disorders
The Role of Psychotropic Medication and BMI
Bibliographic Data
| ID | 8909344 |
|---|---|
| Authors | Mikkel Iwanoff Kolind (0000-0001-5896-8610, Steno Diabetes Centers, corresponding author), Christoph P Beier (0000-0001-8268-1492, University of Southern Denmark), Niels-Peter Brøchner Nygaard (0000-0002-5488-5110, University of Southern Denmark), Elsebeth Stenager (0000-0002-4752-3648, University of Southern Denmark), Claus Bogh Juhl (0000-0002-4285-5459, Steno Diabetes Centers) |
| Year | 2025 |
| Volume | 62 |
| Issue | 3 |
| Pages | 432-442 |
| Publication date | 2025-11-11 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Community Mental Health Journal (JOURNAL) |
| Journal identifiers | ISSN: 0010-3853 • E-ISSN: 1573-2789 |
| Publisher | Springer Science+Business Media (PUBLISHER • DE) |
| DOI | 10.1007/s10597-025-01536-y |
| PMID | 41217585 |
| OpenAlex | W4416136506 |
| Language | EN |
| References cited | 39 |
Obesity-associated diseases, such as type 2 diabetes, metabolic syndrome, and dyslipidemia, are common in individuals with mental disorders. The relative contribution of mental disorders, psychotropic medication, and BMI remains unclear. In this cross-sectional study, individuals aged 18-60 years with a BMI ≥ 30 kg/m2 were referred to the University Hospital of Southern Denmark, Esbjerg, and screened for diabetes, prediabetes, metabolic syndrome, hypertension, blood lipid abnormalities, liver disease, and sleep apnea. Individuals with mental disorders were compared to those without using binomial logistic regression adjusted for BMI, age, sex, and use of psychotropic medication. We included 345 participants with and 317 without mental disorders, all with BMI ≥ 30 kg/m 2 . Participants with mental disorders were younger (40.9 ± 10.9 vs. 44.2 ± 10.8 years) and had higher BMI (42.8 ± 7.9 vs. 40.9 ± 6.4 kg/m2). Adjusted analyses showed no increased odds of obesity-related disease except for blood lipid abnormalities and steatosis. BMI significantly influenced most models but not the association with blood lipid abnormalities. Apart from blood lipid abnormalities and steatosis, obesity-related diseases in individuals with mental disorders appears to be largely attributable to obesity. Weight management should be prioritized, with additional focus on blood lipid abnormalities
Blood lipids · Body mass index · Disease · Logistic regression · Mental health · Obesity · Odds · Odds ratio · Psychotropic medication · Bariatric Surgery and Outcomes · Bipolar Disorder and Treatment · Schizophrenia research and treatment
Health Effects of Overweight and Obesity in 195 Countries over 25 Years
Use and Abuse of Homa Modeling
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder
Diagnosis and Management of the Metabolic Syndrome
| Highly cited | No |
|---|